Sara Bonstein
Directeur Financier/CFO chez INSMED INCORPORATED
Fortune : 6 M $ au 31/05/2024
Profil
Sara M.
Bonstein is an Independent Director at scPharmaceuticals, Inc., Xilio Therapeutics, Inc., and a Chief Financial Officer at Insmed, Inc. She previously worked as a Director-Development Finance at ImClone LLC from 2004 to 2014, Finance Director at Eli Lilly & Co., CFO, Secretary, Treasurer & Executive VP at Advaxis, Inc. from 2014 to 2018, and Secretary, Chief Operating & Financial Officer at OncoSec Medical, Inc. from 2018 to 2020.
She holds an undergraduate degree from The College of New Jersey and an MBA from Rider University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSMED INCORPORATED
0,07% | 29/05/2024 | 117 481 ( 0,07% ) | 6 M $ | 31/05/2024 |
SCPHARMACEUTICALS, INC.
-.--% | 11/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
XILIO THERAPEUTICS INC
-.--% | 14/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Sara Bonstein
| Sociétés | Poste | Début |
|---|---|---|
| INSMED INCORPORATED | Directeur Financier/CFO | 31/01/2020 |
| SCPHARMACEUTICALS INC. | Directeur/Membre du Conseil | 08/07/2020 |
| XILIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/08/2021 |
Anciens postes connus de Sara Bonstein
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Directeur Financier/CFO | 30/01/2020 |
| AYALA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 30/04/2018 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/02/2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Sara Bonstein
| The College of New Jersey | Undergraduate Degree |
| Rider University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| INSMED INCORPORATED | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| SCPHARMACEUTICALS INC. | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
